Nat Rev Immunol (2019) 19(5):28290
Found is a telehealth weight loss platform that connects members with licensed clinicians for personalized weight loss care, including access to GLP-1 medications when appropriate
These observations suggest a potential immunometabolic mechanism linking GLP-1 signaling and mast cell activation, highlighting a novel therapeutic avenue for antihistamine-resistant CSU
It suppresses the release of glucagon, a hormone that raises blood-sugar levels by prompting the liver to release stored glucose
This approach is often combined with vitamin C and B-complex infusions to enhance antioxidant synergy
About the author Caroline Catherman Caroline Catherman is a reporter at Healthcare Brew, where she focuses on major payers, health insurance developments, Medicare and Medicaid, policy, and health tech.